Document Detail


A randomized double-blind study using CaNa2EDTA, a phospholipase A2 inhibitor, in the management of human acute pancreatitis.
MedLine Citation:
PMID:  3922048     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a randomized double-blind study the effect of CaNa2EDTA, a phospholipase A2 inhibitor, was tested as a treatment for acute pancreatitis. CaNa2EDTA was infused intravenously during the first 2 days after admission to hospital, in addition to normal conservative treatment. CaNa2EDTA decreased the serum phospholipase A2 activity and appeared to promote recovery from the illness. To what extent the inhibition of serum phospholipase activity may prevent the progress of severe haemorrhagic pancreatitis or diminish mortality and morbidity in acute pancreatitis should be investigated in further studies.
Authors:
H T Tykkä; E J Vaittinen; K L Mahlberg; J E Railo; P J Pantzar; S Sarna; T Tallberg
Related Documents :
21206138 - A case of myxedema coma caused by isolated thyrotropin stimulating hormone deficiency a...
3575298 - Serum zinc levels in sheep with experimental pancreatic abnormalities.
7691208 - Dose-response effect of intraduodenal hcl on exocrine pancreatic secretion, portal secr...
12843638 - Screening of mongolian plants for influence on amylase activity in mouse plasma and gas...
18006938 - Intra-individual variation of plasma adipokine levels and utility of single measurement...
3134578 - Effects of sex hormones on rabbit gallbladder prostaglandin biosynthesis.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Scandinavian journal of gastroenterology     Volume:  20     ISSN:  0036-5521     ISO Abbreviation:  Scand. J. Gastroenterol.     Publication Date:  1985 Jan 
Date Detail:
Created Date:  1985-06-03     Completed Date:  1985-06-03     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0060105     Medline TA:  Scand J Gastroenterol     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  5-12     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Annexins
Calcium-Binding Proteins*
Clinical Trials as Topic
Double-Blind Method
Edetic Acid / therapeutic use*
Female
Glycoproteins / therapeutic use*
Humans
Male
Middle Aged
Pancreatitis / drug therapy*,  metabolism
Phospholipases / antagonists & inhibitors*
Phospholipases A / antagonists & inhibitors*
Phospholipases A2
Random Allocation
Chemical
Reg. No./Substance:
0/Annexins; 0/Calcium-Binding Proteins; 0/Glycoproteins; 0/lipomodulin; 60-00-4/Edetic Acid; EC 3.1.-/Phospholipases; EC 3.1.1.-/Phospholipases A; EC 3.1.1.4/Phospholipases A2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Simulated meal test. A new method for estimation of parietal and non-parietal secretion in response ...
Next Document:  Proportions of Ig classes and subclasses in rubella antibodies.